Search
Search Results
-
Budget impact analyses for treatment of heart failure. A systematic review
Heart failure (HF) is increasing globally and turning out to be a serious worldwide public health problem with significant morbidity and mortality....
-
Budget impact of increasing uptake of denosumab for the treatment of postmenopausal osteoporosis in Malaysia
SummaryThis study evaluated the financial impact of increasing denosumab usage for managing postmenopausal osteoporosis over a 5-year period from the...
-
Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina
ObjectivesTo perform a budget impact analysis (BIA) of introducing olaparib as maintenance therapy in women who have BRCA mutations (BRCAm) with...
-
Budget impact analysis of a digital monitoring platform for COPD
BackgroundChronic obstructive pulmonary disease (COPD) is a progressive debilitating condition with frequent exacerbations that have a high burden...
-
The role of budget impact and its relationship with cost-effectiveness in reimbursement decisions on health technologies in the Netherlands
Health authorities using cost-effectiveness analysis (CEA) for informing reimbursement decisions on health technologies increasingly require economic...
-
Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus
ObjectiveThis study aims to estimate the budget impact of luspatercept reimbursement as an adjuvant to the standard management of β-thalassaemia...
-
Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective
IntroductionGliflozins have historically been indicated for type 2 diabetes in France. However, their efficacy has recently been demonstrated in...
-
Cost-effectiveness and budget impact analysis of Daratumumab, Lenalidomide and dexamethasone for relapsed-refractory multiple myeloma
BackgroundThe prominent efficacy in terms of increasing progression-free survival (PFS) of Daratumumab, Lenalidomide and dexamethasone (DRd) triplet...
-
Budget Impact Analysis of Intensification with iGlarLixi Compared to Alternative Treatment Strategies Among Patients with Type 2 Diabetes Mellitus
IntroductionThe clinical benefits of treating patients with type 2 diabetes mellitus (T2DM) with fixed-ratio combination of insulin iGlar (iGlar)...
-
Estimating the budget impact of a Tuberculosis strategic purchasing pilot study in Medan, Indonesia (2018–2019)
BackgroundIndonesia has the world’s second-highest tuberculosis (TB) burden, with 969,000 annual TB infections. In 2017, Indonesia faced significant...
-
Budget impact analysis of continuous glucose monitoring in individuals with type 2 diabetes on insulin treatment in England
IntroductionIn 2022, updated guidance from NICE expanded the options for self-monitoring of blood glucose for patients with type 2 diabetes (T2DM),...
-
Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis
BackgroundMultiple sclerosis is an inflammatory demyelination process in the central nervous system (CNS) causing neurological disability and poor...
-
Cost-Effectiveness and Budget Impact Analyses of Patient Blood Management in a Cardiovascular Surgery Department at Ankara Bilkent City Hospital in Turkey
IntroductionAnemia and transfusion of blood products are risk factors associated with poor patient outcomes across all elective surgeries. Patient...
-
Cost-utility and budget impact analyses of cervical cancer screening using self-collected samples for HPV DNA testing in Thailand
IntroductionCervical cancer ranks as the third most prevalent cancer among women in Thailand. However, the effectiveness of cervical cancer screening...
-
A mixed methods partner-focused cost and budget impact analysis to deploy implementation strategies for school-based prevention
BackgroundObtaining information on implementation strategy costs and local budget impacts from multiple perspectives is essential to data-driven...
-
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis
AimIn 2022, in Italy, general practitioners (GPs) have been allowed to prescribe SGLT2i in Type 2 Diabetes (T2D) under National Health Service (NHS)...
-
Budget Impact of Introducing Fixed-Duration Mosunetuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy in the USA
ObjectiveThis study aimed to assess the budget impact of introducing fixed-duration mosunetuzumab as a treatment option for adult patients with...
-
Budget Impact Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) for Preventing Recurrent Clostridioides difficile Infection in the US
IntroductionPatients with Clostridioides difficile infection (CDI) often experience recurrences (rCDI), which are associated with high morbidity,...
-
Budget Impact Analysis of the Introduction of a Trastuzumab Biosimilar for HER2-Positive Breast Cancer in China
Background and ObjectiveBiosimilars provide the possibility to reduce the high expenditure on biologic drugs and expand access to effective but less...
-
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy
BackgroundRecent developments improved outcomes in patients with autoimmune diseases. Biologics were approved as first-line treatment in selected...
